Ann: Placement of $10m Closed Significantly Oversubscribed, page-54

First 54 Last

Share
Profile

Follow
kroehny17

1,105 Posts.

17/03/17

12:44

Post #: 23430504
Share

Originally posted by pnh88 ↑

Unlikely that the SP will fall to 6.5c or below:
1. When you go on the market asking for 10m no one is interested unless you offer stock at a discount...and it was by 25% odd. Not that unreasonable for that amount of money and that amount of risk
2. There is now $13 odd mil sitting in assets. Some of that will be used for first class travel a lot of Champaign and some more "success cash bonus's" especially for BM who engineered and capitalized on the speculation.
3. The board has a wealth of knowledge on MM, growing conditions and extraction of CBD oil methodology, or at least we hope they have and are not being used by BM to increase his own wealth at punters expense. ie token directors.
4. Looking at AC8 since when this madness started they can provide a guideline as to the potential valuation that MXC could rise to based on todays SP. My calcs show around 8.3c, but if MXC can be believed they are in a better position wrt future cash flows from cosmetics and their relatively comparitive cash position.
5. We don't have any ANN wrt import license yet. The market is assuming that this will be a formality!
6. No authority to grow MM in Aussy so far but the market is assuming that this will also be a formality or rubber stamp.

To fall below 6.5c there would need to be a complete loss of faith in the whole industry for whatever reason.

Expand

Nice post!

It is true that because of the huge volatility in weed stocks recently that for such a large raise they probably had to offer a greater discount due to the chance that it cools and falls quite significantly lower.

MXC Price at posting: 7.9¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

Failure to report prompts ASX to impose multiple company suspensions

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

IRE

Iress runs 'hot' for Wealth Within's stock tips

LU7

Strong PFS numbers solidify Lithium Universe's big plans for Québec

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 23 more messages in this thread...

First 54 Last

Add RGT (ASX) to my watchlist

(20min delay)
Last 53.0¢		Change 0.180(51.4%)		Mkt cap ! $25.65M

Open	High	Low	Value	Volume
38.0¢	56.0¢	38.0¢	$71.38K	137.5K

Buyers (Bids)

No.	Vol.	Price($)
1	334	51.0¢

Sellers (Offers)

Price($)	Vol.	No.
55.0¢	60	1

View Market Depth

No.	Vol.	Price($)
1	334	0.510
1	680	0.470
1	2000	0.460
1	5000	0.450
2	9000	0.445

Price($)	Vol.	No.
0.550	60	1
0.590	2000	1
0.620	1414	1
0.700	1368	1
0.740	350	1

Last trade - 16.10pm 01/10/2024 (20 minute delay)

RGT (ASX) Chart

Ann: Placement of $10m Closed Significantly Oversubscribed, page-54

Failure to report prompts ASX to impose multiple company suspensions

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Iress runs 'hot' for Wealth Within's stock tips

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Placement of $10m Closed Significantly Oversubscribed, page-54

Top Stories

Failure to report prompts ASX to impose multiple company suspensions

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Iress runs 'hot' for Wealth Within's stock tips

Strong PFS numbers solidify Lithium Universe's big plans for Québec

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News